Geisinger E, Isberg RR. Interplay between antibiotic resistance and virulence during disease promoted by multidrug-resistant bacteria. J Infect Dis. 2017;215(Suppl 1):9–17.
Article
Google Scholar
Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother. 1995;39:577–85.
Article
CAS
Google Scholar
Bouchiat C, El-Zeenni N, Chakrakodi B, Nagaraj S, Arakere G, Etienne J. Epidemiology of Staphylococcus aureus in Bangalore, India: emergence of the ST217 clone and high rate of resistance to erythromycin and ciprofloxacin in the community. New Microbes New Infect. 2015;7:15–20.
Article
CAS
Google Scholar
Schmitz FJ, Petridou J, Jagusch H, Astfalk N, Scheuring S, Schwarz S. Molecular characterization of ketolide-resistant erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycin. J Antimicrob Chemother. 2002;49:611–7.
Article
CAS
Google Scholar
Gupta P, Kannan K, Mankin AS, Vázquez-Laslop N. Regulation of gene expression by macrolide-induced ribosomal frameshifting. Mol Cell. 2013;52:629–42.
Article
CAS
Google Scholar
Zhanel GG, Hartel E, Adam H, Zelenitsky S, Zhanel MA, Golden A, Schweizer F, Gorityala B, Lagacé-Wiens PR, Walkty AJ, Gin AS, Hoban DJ, Lynch JP, Karlowsky JA. Solithromycin: a novel fluoroketolide for the treatment of community-acquired bacterial pneumonia. Drugs. 2016;76:1737–57.
Article
CAS
Google Scholar
Farrell DJ, Flamm RK, Sader HS, Jones RN. Results from the Solithromycin international surveillance program (2014). Antimicrob Agents Chemother. 2016;60:3662–8.
Article
CAS
Google Scholar
File TM Jr, Rewerska B, Vucinic-Mihailovic V, Gonong JRV, Das AF, Keedy K, Taylor D, Sheets A, Fernandes P, Oldach D, Jamieson BD. SOLITAIRE-IV: a randomized, double-blind, multicenter study comparing the efficacy and safety of intravenous-to-oral solithromycin to intravenous-to-oral moxifloxacin for treatment of community-acquired bacterial pneumonia. Clin Infect Dis. 2016;63:1007–16.
Article
CAS
Google Scholar
Chancey ST, Zähner D, Stephens DS. Acquired inducible antimicrobial resistance in Gram-positive bacteria. Future Microbiol. 2012;7:959–78.
Article
CAS
Google Scholar
Kobayashi N, Wu H, Kojima K, Taniguchi K, Urasawa S, Uehara N, Omizu Y, Kishi Y, Yagihashi A, Kurokawa I. Detection of mecA, femA, and femB genes in clinical strains of staphylococci using polymerase chain reaction. Epidemiol Infect. 1994;113:259–66.
Article
CAS
Google Scholar
Yoon EJ, Kwon AR, Min YH, Choi EC. Foggy D-shaped zone of inhibition in Staphylococcus aureus owing to a dual character of both inducible and constitutive resistance to macrolide-lincosamide-streptogramin B. J Antimicrob Chemother. 2008;61:533–40.
Article
CAS
Google Scholar
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Sixth Informational Supplement M100-S26. Wayne: CLSI; 2016.
Google Scholar
Locke JB, Hilgers M, Shaw KJ. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob Agents Chemother. 2009;53:5265–74.
Article
CAS
Google Scholar
Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother. 1996;40:2562–6.
Article
CAS
Google Scholar
Drago L, De Vecchi E, Nicola L, Colombo A, Gismondo MR. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides. J Antimicrob Chemother. 2004;54:542–5.
Article
CAS
Google Scholar
McGhee P, Clark C, Kosowska-Shick KM, Nagai K, Dewasse B, Beachel L, Appelbaum PC. In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms. Antimicrob Agents Chemother. 2010;54:230–8.
Article
CAS
Google Scholar
Walsh F, Willcock J, Amyes S. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae. J Antimicrob Chemother. 2003;52:345–53.
Article
CAS
Google Scholar
Tait-Kamradt A, Reinert RR, Al-Lahham A, Low D, Sutcliffe J. High-level ketolide-resistant streptococci. In: Programs and Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago; Washington, DC: American Society for Microbiology; 2001. p. 101. Abstract C1-1813.
Google Scholar
Farrell DJ, Morrissey I, Bakker S, Felmingham D. Mutations in erm(B) associated with rare, low-level telithromycin resistance in Streptococcus pneumoniae: 3-year data from PROTEKT. In: Programs and Abstracts of the 14th European Congress of Clinical Microbiology and Infectious Diseases. Prague: European Society of Clinical Microbiology and Infectious Diseases; 2004. Abstract P1465.
Google Scholar
Hirakata Y, Mizuta Y, Wada A, Kondoh A, Kurihara S, Izumikawa K, Seki M, Yanagihara K, Miyazaki Y, Tomono K, Kohno S. The first telithromycin-resistant Streptococcus pneumoniae isolate in Japan associated with erm(B) and mutations in 23S rRNA and riboprotein L4. Jpn J Infect Dis. 2007;60:48–50.
CAS
PubMed
Google Scholar
Canu A, Malbruny B, Coquemont M, Davies TA, Appelbaum PC, Leclercq R. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2002;46:125–31.
Article
CAS
Google Scholar
Farrell DJ, Morrissey I, Bakker S, Buckridge S, Felmingham D. In vitro activities of telithromycin, linezolid, and quinupristin–dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations. Antimicrob Agents Chemother. 2004;48:3169–71.
Article
CAS
Google Scholar
Tait-Kamradt A, Davies T, Appelbaum PC, Depardieu F, Courvalin P, Petitpas J, Wondrack L, Walker A, Jacobs MR, Sutcliffe J. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob Agents Chemother. 2000;44:3395–401.
Article
CAS
Google Scholar
Perez-Trallero E, Marimon JM, Iglesias L, Larruskain J. Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates. Emerg Infect Dis. 2003;9:1159–62.
Article
CAS
Google Scholar
Bogdanovich T, Bozdogan B, Appelbaum PC. Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae. Antimicrob Agents Chemother. 2006;50:893–8.
Article
CAS
Google Scholar
Park B, Min YH. Inducible expression of erm(B) by the ketolides telithromycin and cethromycin. Int J Antimicrob Agents. 2015;46:226–7.
Article
CAS
Google Scholar
Sothiselvam S, Liu B, Han W, Ramu H, Klepacki D, Atkinson GC, Brauer A, Remm M, Tenson T, Schulten K, Vázquez-Laslop N, Mankin AS. Macrolide antibiotics allosterically predispose the ribosome for translation arrest. Proc Natl Acad Sci U S A. 2014;111:9804–9.
Article
CAS
Google Scholar
Douthwaite S, Jalava J, Jakobsen L. Ketolide resistance in Streptococcus pyogenes correlates with the degree of rRNA dimethylation by Erm. Mol Microbiol. 2005;58:613–22.
Article
CAS
Google Scholar